Literature DB >> 2432583

Can group- and serovar-specific proteins be detected in Ureaplasma urealyticum?

S A Horowitz, L Duffy, B Garrett, J Stephens, J K Davis, G H Cassell.   

Abstract

Ureaplasma urealyticum has been subspeciated by a number of serologic methods. Eight serotypes have been identified by modified metabolic inhibition, growth inhibition and indirect hemagglutination. Fourteen serovars have been identified by immunofluorescence and 16 by the mycoplasmacidal assay. The present studies were performed to determine if group-specific antigens could be detected by immunofluorescence and if group- or serovar-specific antigens could be detected by enzyme-linked immunosorbent assay and immunoblotting. Reaction of rabbit antisera to U. urealyticum with homologous and heterologous serotypes based upon end point immunofluorescent titration did not differentiate the serovars into the two biotypes. In attempts to quantitate the number of a given serovar present in clinical specimens, the total number of colonies that were stained often exceeded 100%, suggesting either that the serovars represented in stock cultures are not truly representative of those present in humans or that certain strains express multiple serovar specificities. End point titration in an enzyme-linked immunoadsorbent assay using either whole cells or cell lysates and rabbit antisera failed to distinguish between group and serovars (i.e. in many cases end point titers were only 2-fold lower with heterologous antigens). Furthermore convalescent sera from patients infected with a single serovar failed to induce a serovar-specific response detectable in an enzyme-linked immunosorbent assay. Likewise immunoblotting of one dimensional electrophoretograms with sera from humans known to be infected with a single serovar showed that antibodies against that serovar recognized peptides present in all serovars and reacted with those bands with various degrees of intensity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2432583     DOI: 10.1097/00006454-198611010-00029

Source DB:  PubMed          Journal:  Pediatr Infect Dis        ISSN: 0277-9730


  8 in total

1.  Serotype diversity and antigen variation among invasive isolates of Ureaplasma urealyticum from neonates.

Authors:  X Zheng; H L Watson; K B Waites; G H Cassell
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

2.  Ureaplasma urealyticum pneumonia: experimental production and demonstration of age-related susceptibility.

Authors:  P T Rudd; G H Cassell; K B Waites; J K Davis; L B Duffy
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

3.  Serotype 8- and serocluster-specific surface-expressed antigens of Ureaplasma urealyticum.

Authors:  D Thirkell; A D Myles; W C Russell
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

4.  Variable antigens of Ureaplasma urealyticum containing both serovar-specific and serovar-cross-reactive epitopes.

Authors:  H L Watson; D K Blalock; G H Cassell
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

5.  Extensive horizontal gene transfer in ureaplasmas from humans questions the utility of serotyping for diagnostic purposes.

Authors:  Li Xiao; Vanya Paralanov; John I Glass; Lynn B Duffy; Janet A Robertson; Gail H Cassell; Yuying Chen; Ken B Waites
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

Review 6.  Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns.

Authors:  G H Cassell; K B Waites; H L Watson; D T Crouse; R Harasawa
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132

7.  Humoral immune response to polypeptides of Ureaplasma urealyticum in women with postpartum fever.

Authors:  G Y Lee; G E Kenny
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

8.  Mycoplasma genitalium in the joints of two patients with arthritis.

Authors:  D Taylor-Robinson; C B Gilroy; S Horowitz; J Horowitz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-12       Impact factor: 3.267

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.